Exact Mass: 185.0516

Plant growth regulator. Plant growth regulator

N-hydroxy-4-aminobiphenyl

N-Hydroxy-4-aminobiphenyl

2-Amino-3-carboxymuconic acid semialdehyde

(2Z)-2-amino-3-[(1Z)-3-oxoprop-1-en-1-yl]but-2-enedioic acid

2-Amino-3-carboxymuconic acid semialdehyde (CAS: 16597-58-3) is an intermediate metabolite of the tryptophan-niacin catabolic pathway. Current interest in the degradation of tryptophan is mostly due to the role of quinolinate and other metabolites in several neuropathological conditions. Quinolinate is a neurotoxin formed nonenzymatically from 2-amino-3-carboxymuconic semialdehyde in mammalian tissues. 2-Amino-3-carboxymuconic acid semialdehyde is enzymatically converted into 2-aminomuconate via 2-aminomuconic semialdehyde (PMID: 10510494, 16267312, 14275129). 2-amino-3-carboxymuconic acid semialdehyde is an intermediate metabolite of the tryptophan-niacin catabolic pathway. Current interest in the degradation of tryptophan is mostly due to the role of quinolinate and other metabolites in several neuropathological conditions. Quinolinate is a neurotoxin formed nonenzymatically from 2-amino-3-carboxymuconic semialdehyde in mammalian tissues. 2-Amino-3-carboxymuconic semialdehyde is enzymatically converted to 2-aminomuconate via 2-aminomuconic semialdehyde. (PMID: 10510494, 16267312, 14275129) [HMDB]

Cyometrinil

(2E)-2-(cyanomethoxyimino)-2-phenyl-acetonitrile

C10H7N3O (185.0589)

ACMC-20mzul

(2Z,4E)-4-amino-6-oxohepta-2,4-dienedioic acid

(S)-N-(4,5-Dihydro-1-methyl-4-oxo-1H-imidazol-2-yl)alanine

2-[(4-Hydroxy-1-methyl-2,5-dihydro-1H-imidazol-2-ylidene)amino]propanoate

(S)-N-(4,5-Dihydro-1-methyl-4-oxo-1H-imidazol-2-yl)alanine is isolated from beef brot Isolated from beef broth

4-Hydroxydiphenylamine

4-(Phenylamino)phenol, 9ci

4-Hydroxydiphenylamine is found in pomes. Metabolite of Diphenylamine FBK63-A in stored apple

5-(2-Hydroxyethyl)-4-methylthiazole acetate

5-(2-Hydroxyethyl)-4-methylthiazole acetic acid

C8H11NO2S (185.051)

5-(2-Hydroxyethyl)-4-methylthiazole acetate is a flavour ingredient. Flavour ingredient

1-Naphthyl isothiocyanate

alpha-Naphthyl isothiocyanic acid

C11H7NS (185.0299)

2-Methyl-5-nitroimidazol-1-ylacetic acid

2-(2-methyl-5-nitro-1H-imidazol-1-yl)acetic acid

C6H7N3O4 (185.0437)

2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid

(+)-(1S,2S,5R,6S)-2-Aminobicyclo(3.1.0)hexane-2,6-dicarboxylic acid

C8H11NO4 (185.0688)

D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018690 - Excitatory Amino Acid Agonists D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants (rel)-Eglumegad ((rel)-LY354740) is a relative configuration of Eglumegad (HY-18941). Eglumegad is a highly potent and selective group II (mGlu2/3) receptor agonist with EC50s of 5 and 24 nM for transfected human mGlu2 and mGlu3 receptors, respectively[1].

2-Naphthyl isothiocyanate

2-Naphthyl isothiocyanic acid

C11H7NS (185.0299)

6-Fluoropyridoxal

2-fluoro-5-hydroxy-3-(hydroxymethyl)-6-methylpyridine-4-carbaldehyde

C8H8FNO3 (185.0488)

Methyl 4-amino-5-ethyl-3-thiophenecarboxylate

4-Amino-5-ethyl-3-thiophenecarboxylic acid methyl ester

C8H11NO2S (185.051)

Pirfenidone

5-methyl-1-phenyl-1,2-dihydropyridin-2-one

L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C26170 - Protective Agent > C797 - Radioprotective Agent D000893 - Anti-Inflammatory Agents D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Secnidazole

1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-ol

P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases > P01AB - Nitroimidazole derivatives D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

(4S)-4-hydroxy-2,3,4,5-tetrahydro-(2S)-dipicolinate

(2S,4S)-4-hydroxy-2,3,4,5-tetrahydropyridine-2,6-dicarboxylate

(4s)-4-hydroxy-2,3,4,5-tetrahydro-(2s)-dipicolinate belongs to alpha amino acids and derivatives class of compounds. Those are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof (4s)-4-hydroxy-2,3,4,5-tetrahydro-(2s)-dipicolinate is soluble (in water) and a weakly acidic compound (based on its pKa). (4s)-4-hydroxy-2,3,4,5-tetrahydro-(2s)-dipicolinate can be found in a number of food items such as mamey sapote, red bell pepper, burbot, and kelp, which makes (4s)-4-hydroxy-2,3,4,5-tetrahydro-(2s)-dipicolinate a potential biomarker for the consumption of these food products.

L-alpha-amino-epsilon-keto-pimelate

(1,5-dicarboxylato-5-oxopentyl)azaniumyl

Enaminomycin C

2,5-dihydroxy-4-imino-7-oxabicyclo[4.1.0]hept-2-ene-3-carboxylic acid

Enaminomycin C is a metabolite that has been isolated from Streptomyces species, which are a group of bacteria known for their ability to produce a wide array of secondary metabolites with diverse biological activities. Enaminomycin C is one such compound that has been identified and characterized from these bacteria. It belongs to the enediyne antibiotic class, which are complex natural products known for their potent antibacterial activity, particularly against Gram-positive bacteria. Enaminomycin C, like other enediyne antibiotics, is believed to exert its antibacterial effects by targeting the bacterial ribosome and forming a complex with the RNA, leading to the inhibition of protein synthesis and ultimately cell death. The structural features of Enaminomycin C contribute to its unique biological properties. It possesses an enediyne core, which is a key structural element responsible for its antibacterial activity. Additionally, it may have other functional groups or substituents that can influence its pharmacological properties, such as absorption, distribution, metabolism, and excretion. As a natural product with potential antimicrobial activity, Enaminomycin C and other related compounds have been of interest in the field of drug discovery and development. Researchers are interested in understanding their mechanisms of action, as well as exploring the potential for modifying these compounds to improve their therapeutic profiles, such as increasing potency, reducing toxicity, or expanding the spectrum of activity against drug-resistant bacteria. However, it is important to note that while Enaminomycin C has been identified and characterized from Streptomyces species, it may not have been extensively studied or developed into a therapeutic agent. Further research is needed to fully understand its potential as a novel antimicrobial agent and to address any challenges associated with its development, such as synthesis, scalability, and clinical trials.

Ipronidazole-OH

Secnidazole

Ternidazole

2-methyl-5-nitroIMIDAZOLE-1-propanol